Profiel
Hiroyuki Ueno is currently a Director at Alphanavi Pharma KK and an Executive Manager at Kyoto University Innovation Capital Co., Ltd.
He previously worked as an Outside Director at Chordia Therapeutics, Inc.
Actieve functies van Hiroyuki Ueno
| Bedrijven | Functie | Begin |
|---|---|---|
Kyoto University Innovation Capital Co., Ltd.
 Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Private Equity Investor | 01-10-2020 |
Alphanavi Pharma KK
 Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Hiroyuki Ueno
| Bedrijven | Functie | Einde |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CHORDIA THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Kyoto University Innovation Capital Co., Ltd.
Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Finance |
Alphanavi Pharma KK
Alphanavi Pharma KK Pharmaceuticals: MajorHealth Technology Alphanavi Pharma KK is a pharmaceutical company based in Kyoto, Japan that focuses on developing new treatments for chronic pain. The Japanese company's goal is to alleviate discomfort and bring smiles back to patients and their families. The company was founded in 2019 by Yoshihiro Koyamada. | Health Technology |
